Friday 29 Mar 2024
By
main news image

This article first appeared in The Edge Malaysia Weekly on May 23, 2022 - May 29, 2022

COVID-19 VACCINE DEVELOPMENTS

 

The World Health Organization has granted emergency use authorisation for the coronavirus vaccine made by China’s CanSino Biologics, the 11th such shot to receive the green light. The United Nations health agency said the single-dose CanSino vaccine was found to be about 92% effective against severe Covid-19 and 64% effective in preventing people from getting symptoms of the disease.

 


The US Food and Drug Administration has authorised the use of a booster shot of Pfizer/BioNTech’s Covid-19 vaccine for children aged five to 11.

 


The European Union’s medicine regulator accepted Valneva’s filing of marketing authorisation application for its inactivated Covid-19 vaccine candidate.

 


Pharmaniaga Bhd is setting up a RM300 million halal insulin and vaccine plant in Puchong, Selangor, which is expected to be fully completed by end-2023.

 


The US Centers for Disease Control and Prevention on Thursday said reports of heart inflammation linked to the Pfizer/BioNTech Covid-19 vaccine have been much lower in five- to 11-year-old boys than in adolescents and young men, representing only a slightly elevated rate than normal.

e

 

 

Save by subscribing to us for your print and/or digital copy.

P/S: The Edge is also available on Apple's AppStore and Androids' Google Play.

      Print
      Text Size
      Share